Medroxyprogesterone Acetate clinical trials
Also written DMPA, Provera, Depo-Provera and TV-46046.
A product of Medroxyprogesterone; its studies count on that page too.
How each study uses Medroxyprogesterone Acetate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Medroxyprogesterone Acetate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 18 Jun 1959 · PROVERA · NDA 011839 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
73 studies that test it; most in 2015 (9); 1 more planned to start later
| Year | Studies |
|---|---|
| 1996 | 1 |
| 1999 | 1 |
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 9 |
| 2016 | 1 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 9 · Other 65
FHI 360 (5) · Teva Branded Pharmaceutical Products R&D, Inc. (3) · Pfizer (2) · University of Washington (2) · Assiut University (2) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (2) · Botswana Harvard AIDS Institute Partnership (1) · Northwestern University (1)
Often tested with
Tested in the same studies.
Levonorgestrel (3) · Conjugated estrogens (3) · Contraceptives, Oral, Combined (2) · Dydrogesterone (2) · Estradiol (2) · Megestrol Acetate (2) · Megestrol (2) · Letrozole (2)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Medroxyprogesterone
- One of Hormonal contraceptives source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Medroxyprogesterone Acetate.
- Nov 2027A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)Phase 2 · Merck Sharp & Dohme LLC
Studies
Open first, then newest update. How each study uses Medroxyprogesterone Acetate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 74
- Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-ANot yet recruitingPhase 3ShangHai Ji Ai Genetics & IVF InstituteNCT05326087Written as MPA
- Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell DiseaseRecruitingPhase 4University of PennsylvaniaNCT06665997Written as Depot medroxyprogesterone acetate (DMPA)
- A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)RecruitingPhase 2Merck Sharp & Dohme LLCNCT06979596Written as Megestrol acetate/Medroxyprogesterone acetate
- Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular ClassificationRecruitingPhase 2/3Fudan UniversityNCT07319429Written as Medroxyprogesterone Acetate 500 MG
- Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and VomitingNot yet recruitingPhase 3The First Affiliated Hospital of Xinxiang Medical CollegeNCT07124195Written as Medroxyprogesterone acetate oral suspension
- Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.Not yet recruitingPhase 4GinefivNCT06637189Written as Medroxyprogesterone Acetate 10 MG
- Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial HyperplasiaRecruitingPhase 2Peking University People's HospitalNCT05675787Written as Medroxyprogesterone acetate + Atorvastatin
- Medroxyprogesterone Acetate vs LNG-IUS in Early-stage Endometrioid Carcinoma and Atypical Hyperplasia PatientsRecruitingPhase 2/3Hua LiNCT05565573Written as Medroxyprogesterone Acetate 500 MG Oral Tablet
- Continuation of Subcutaneous and Intramuscular Depot Medroxyprogesterone Acetate in Post-abortion PatientsCompletedPhase 4Northwestern UniversityNCT05505435Written as Depot-Medroxyprogestereone Acetate
- Endometrial Biopsy in Progestin Contraceptive UsersCompletedEarly Phase 1Oregon Health and Science UniversityNCT05760144Written as DMPA
- Risk Evaluation and Screening to Tailor Prevention and Reduce the Incidence of Endometrial CancerCompletedPhase 4University of British ColumbiaNCT05651282Written as Provera
- Measuring Lactation Initiation After Early Postpartum Injectable Progestin (DMPA) Use Among Women in Dhanusha District of Nepal: A Pilot StudyCompletedPhase 4University of California, San DiegoNCT06816901Written as Depo Medroxyprogesterone acetate
- A Study Comparing Subcutaneous Injection of Sayana Press In the Upper Arm Versus Anterior Thigh and AbdomenCompletedPhase 1PfizerNCT04893798Written as Sayana Press
- Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative SurgeryCompletedPhase 3Universitas DiponegoroNCT06145438Written as Depo Medroxyprogesterone acetate
- Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation CyclesCompletedNot applicableBezmialem Vakif UniversityNCT05767086Written as Medroxyprogesterone Acetate (Tarlusal)
- Sayana® Press Extension StudyCompletedPhase 3FHI 360NCT03154125Written as Sayana® Press
- Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal WomenCompletedPhase 1Teva Pharmaceuticals USANCT00830414Written as medroxyprogesterone acetate
- The Kampala Women's Bone StudyCompletedPhase 4University of WashingtonNCT03464266Written as FTC/TDF and DMPA
- Postpartum Family PlanningTerminatedPhase 4Ohio State UniversityNCT03844633Written as Depo-Provera Injectable Product
- Tranexamic Acid and Depot-Medroxyprogesterone Acetate for Perimenopausal Irregular Uterine BleedingCompletedNot applicableAssiut UniversityNCT04710017Written as Medroxyprogesterone Acetate 150 MG/ML
See all 74 studies that test Medroxyprogesterone Acetate →
Given beside what is tested · 10 — Medroxyprogesterone Acetate is usual care or a partner of the new treatment
- A Study of TCD601 in de Novo Renal Transplant RecipientsCompletedPhase 2ITB-Med LLCNCT05669001Written as MPA
- Estrogen Receptor Beta and MoodCompletedPhase 2National Institute of Mental Health (NIMH)NCT03689543Written as Provera
- Pilot Study of Femring Estrogen Supplementation During Depo-Provera InitiationCompletedNot applicableColumbia UniversityNCT00563576Written as DepoProvera ®
- Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial CancerCompletedEarly Phase 1National Cancer Institute (NCI)NCT03018249Written as Medroxyprogesterone Acetate
- Research Investigation of Soy and EstrogenCompletedPhase 2University of Illinois at ChicagoNCT00997893Written as Medroxyprogesterone Acetate (MPA)
- Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and SteroidsCompletedPhase 4NovartisNCT00284947Written as MMF/EC-MPS
- Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel UseCompletedPhase 1CONRADNCT01421368Written as Depo-medroxyprogesterone acetate (DMPA)
- Somatropin Treatment to Final Height in Turner SyndromeCompletedPhase 3Eli Lilly and CompanyNCT00191113Written as Medroxyprogesterone acetate
- Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration AddendumCompletedPhase 1/2University of WashingtonNCT00156650Written as Depo-Medroxyprogesterone
- Male Hormonal Contraceptive Development-ACY-5CompletedPhase 1/2University of WashingtonNCT00161447Written as Depo-Medroxyprogesterone
As the comparator · 14 — what is tested is compared with Medroxyprogesterone Acetate
- Oral GnRH Antagonist (Linzagolix) Versus Injectable GnRH Antagonist in Controlled Ovarian Stimulation for In Vitro Fertilization: A Randomized Controlled Non-Inferiority Trial With a Concurrent Comparator Cohort Undergoing Progestin-Primed Ovarian Stimulation (PPOS)Not yet recruitingNot applicableCentro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita)NCT07732348Written as Medroxyprogesterone Acetate ; Micronized Progesterone
- Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial CancerActive, not recruitingPhase 2Fudan UniversityNCT05247268Written as Medroxyprogesterone Acetate 500 MG
- Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 MonthsWithdrawnPhase 3BayerNCT06904274Written as Medroxyprogesterone acetate
- Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial CancerCompletedPhase 2GOG FoundationNCT02228681Written as Medroxyprogesterone Acetate
- The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic DisorderCompletedPhase 4Far Eastern Memorial HospitalNCT01822288Written as Estradiol & medroxyprogesterone acetate
- Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of EndometriosisCompletedPhase 2AbbVieNCT00437658Written as Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)
- Efficacy of Cyclic DSG Compared With Cyclic MPA for the Treatment of Anovulatory DUBStatus unknownPhase 3Mahidol UniversityNCT02103764Written as Medroxyprogesterone acetate
- Bioidentical 'Natural' Hormone Evaluation in Early MenopauseTerminatedPhase 2Jeanne Drisko, MD, CNS, FACNNCT00302731Written as equine estrogens m-progesteroneacetate
- Lower Dose Depo Provera® Contraceptive InjectionCompletedPhase 1FHI 360NCT02732418Written as Depo-subQ 104
- "Stair Step Study"CompletedPhase 4Radboud University Medical CenterNCT03309176Written as Medroxyprogesterone Acetate 10 MG
- Long-Acting Reversible ContraceptionCompletedPhase 4FHI 360NCT01299116Written as DMPA
- Safety of the Etonogestrel-releasing Implant During the Puerperium of Healthy WomenCompletedNot applicableUniversity of Sao PauloNCT00828542Written as depot medroxyprogesterone acetate
- Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)CompletedPhase 3BayerNCT00360490Written as Medroxyprogesterone acetate
- Multi-centre Clinical Trial on Hormone Replacement Treatment in ChinaStatus unknownPhase 4Peking Union Medical College HospitalNCT01698164Written as estradiol plus MPA
Codes
What other systems call Medroxyprogesterone Acetate · ClinicalTrials.gg INT008565
- MeSH (NLM) D017258Medroxyprogesterone AcetateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) C2QI4IOI2GMEDROXYPROGESTERONE ACETATEConfirmed FDA, NLM, Wikidata
- RxNorm 1000112Confirmed FDA, Wikidata
- Wikidata Q2823834medroxyprogesterone acetateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1155Medroxyprogesterone AcetateOne source FDA
- DrugBank DB00603One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D017258 | Medroxyprogesterone Acetate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | C2QI4IOI2G | MEDROXYPROGESTERONE ACETATE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1000112 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2823834 | medroxyprogesterone acetate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1155 | Medroxyprogesterone Acetate | One source FDA |
| DrugBank | DB00603 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.